News & Announcements

ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to all Lower Middle-Income Countries

TB Alliance and the Medicines Patent Pool Sign Memorandum of Understanding to Improve Access to TB Medicines in Resource-Limited Nations

The Medicines Patent Pool Statement on the US Food and Drug Administration’s Approval of Tenofovir Alafenamide Combination

Upcoming events

29 April – 1 May

UAEM European Conference
Berlin, Germany
MPP’s Advocacy Officer will be presenting on Sunday 1 May

Recent Highlights

Generics Bulletin: “Medicines Patent Pool has potential for wider scope”

Read the article

Expression of Interest

MPP invites Expressions of Interest from potential sub-licensees for the licence to manufacture and sell formulations containing lopinavir and ritonavir. 

MPP Submission to the UN High-Level Panel on Access to Medicines

Read the MPP submission.

MPP Newsletter – January 2016

One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.

Global Innovative Financing for the Next Decade

Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine